Metallo supramolecular cylinders inhibit HIV-1 TAR-TAT complex formation and viral replication in cellulo. 2018

Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
School of Chemistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

Shape-selective recognition of nucleic acid structures by supramolecular drugs offers the potential to treat disease. The Trans Activation Response (TAR) region is a region of high secondary structure within the human immunodeficiency virus-1 (HIV-1) RNA that complexes with the virus-encoded Transactivator protein (TAT) and regulates viral transcription. Herein, we explore different metallo-supramolecular triple stranded helicates (cylinders) that target the TAR bulge motif and inhibit the formation of TAR-TAT complexes and HIV infection. Cylinders that incorporate Ni(II) and Ru(II) showed the most potent anti-viral activity with limited evidence of cellular cytotoxicity. These metallo-supramolecular compounds provide an exciting avenue for developing a new class of anti-viral agents.

UI MeSH Term Description Entries
D009532 Nickel A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012413 Rubidium An element that is an alkali metal. It has an atomic symbol Rb, atomic number 37, and atomic weight 85.47. It is used as a chemical reagent and in the manufacture of photoelectric cells.
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054322 tat Gene Products, Human Immunodeficiency Virus Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV Transacting Transcription Protein,HIV tat Protein,Trans-Acting Transcription Factor, HIV,Trans Acting Transcription Factor, HIV,tat Protein, HIV
D056831 Coordination Complexes Neutral or negatively charged ligands bonded to metal cations or neutral atoms. The number of ligand atoms to which the metal center is directly bonded is the metal cation's coordination number, and this number is always greater than the regular valence or oxidation number of the metal. A coordination complex can be negative, neutral, or positively charged. Metal Complexes,Complexes, Coordination,Complexes, Metal
D038621 Regulatory Sequences, Ribonucleic Acid Sequences within RNA that regulate the processing, stability (RNA STABILITY) or translation (TRANSLATION, GENETIC) of RNA. RNA Regulatory Sequences,Ribonucleic Acid Regulatory Sequences,Regulatory RNA Region,Regulatory Ribonucleic Acid Region,Regulatory Sequences, RNA,RNA Region, Regulatory,RNA Regions, Regulatory,RNA Regulatory Sequence,Regulatory RNA Regions,Regulatory Sequence, RNA,Sequences, RNA Regulatory

Related Publications

Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
November 1997, Nucleic acids research,
Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
December 2009, Bioorganic & medicinal chemistry letters,
Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
July 2016, Scientific reports,
Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
April 1996, FEBS letters,
Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
January 2017, Current pharmaceutical design,
Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
June 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
January 2003, Biochemical and biophysical research communications,
Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
January 2023, Methods in molecular biology (Clifton, N.J.),
Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
July 2017, The Biochemical journal,
Lucia Cardo, and Isabel Nawroth, and Peter J Cail, and Jane A McKeating, and Michael J Hannon
December 1998, Journal of biomolecular structure & dynamics,
Copied contents to your clipboard!